resTORbio, Inc.
(NASDAQ : TORC)

( )
TORC PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.41%202.721.3%$426.59m
BIIBBiogen Inc.
-2.46%220.061.3%$391.11m
GILDGilead Sciences, Inc.
-0.49%64.910.9%$378.65m
CELGCelgene Corporation
1.13%102.951.3%$367.47m
ILMNIllumina, Inc.
-0.36%309.443.5%$247.45m
REGNRegeneron Pharmaceuticals, Inc.
-0.46%300.192.6%$218.58m
EXASExact Sciences Corporation
-0.95%96.4724.1%$199.33m
VRTXVertex Pharmaceuticals Incorporated
-0.84%176.231.9%$176.44m
ALXNAlexion Pharmaceuticals, Inc.
-1.58%98.412.0%$169.95m
AAgilent Technologies, Inc.
-0.44%74.591.6%$143.57m
SRPTSarepta Therapeutics, Inc.
-1.91%85.7714.6%$132.47m
BMRNBioMarin Pharmaceutical Inc.
1.84%69.154.3%$96.30m
SGENSeattle Genetics, Inc.
1.70%87.406.2%$95.18m
NKTRNektar Therapeutics
-2.81%17.275.5%$84.77m
ALDRAlder Biopharmaceuticals, Inc.
0.11%18.9210.2%$81.63m

Company Profile

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.